KONTRASTMITTEL

European patent · EP3717025 · In force

Register entry

Publication number
EP3717025
Application number
EP18811010
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 27, 2018
Published
Oct 7, 2020
Granted
Nov 3, 2021
Protection ends at the latest
Nov 26, 2038
Next annual fee due
Nov 30, 2026
IPC classes
A61K 51/04 (2006.01)
C07B 59/00 (2006.01)
C07D 491/048 (2006.01)
A61K 101/00 (2006.01)
A61K 101/02 (2006.01)
Priority
EP 17204896 01.12.2017
PCT application
PCT/EP2018/082649 27.11.2018
PCT publication
WO2019/105913 06.06.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Sep 14, 2022

    Change

    Published in Swissreg on 14.09.2022

  6. Nov 3, 2021

    Granted

    Published in Swissreg on 03.11.2021

Parties

Holder

UCB Biopharma SRL

Allée de la Recherche 60, 1070 Brussels, BE

Inventor

MAGUIRE, Ralph

1070 Brussels, BE

VALADE, Anne

1070 Brussels, BE

MERCIER, Joël

1070 Brussels, BE

WOOD, Martyn

Brussels 1070, BE

VERMEIREN, Celine

1070 Brussels, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.